1. Home
  2. Stocks
  3. Kpl Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Kwality Pharmaceuticals Share Price

    Small Cap
    ₹766.35
    -33.35 (-4.17%)
    19 September, 2024 13:38 BSE: 539997 NSE: KPL ISIN: INE552U01010

    Start SIP in Kwality Pharmaceuticals

    Start SIP

    Kwality Pharmaceuticals Performance

    Day Range

    • Low 0
    • High 0
    ₹ 766

    52 Week Range

    • Low 0
    • High 0
    ₹ 766
    • Open Price0
    • Previous Close0
    • Volume

    Kwality Pharmaceuticals Chart

    • Over 1 Month + 32.86%
    • Over 3 Month + 39.81%
    • Over 6 Month + 72.29%
    • Over 1 Year + 101.72%

    Kwality Pharmaceuticals Key Statistics

    Kwality Pharmaceuticals Investment Rating

    • Master Rating:

    • M K Proteins has an operating revenue of Rs. 226.71 Cr. on a trailing 12-month basis. An annual revenue de-growth of -22% needs improvement, Pre-tax margin of 6% is okay, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 59 indicates it belongs to a fair industry group of Food-Packaged and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Kwality Pharmaceuticals Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 809278706769
    Operating Expenses Qtr Cr 637161545457
    Operating Profit Qtr Cr 172117151412
    Depreciation Qtr Cr 455554
    Interest Qtr Cr 233222
    Tax Qtr Cr 32222-2
    Net Profit Qtr Cr 84865-7
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 309254
    Operating Expenses Annual Cr 241191
    Operating Profit Annual in Cr 6760
    Depreciation Cr 2015
    Interest Annual Cr 106
    Tax Annual Cr 76
    Net Profit Annual Cr 2419
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 4342
    Cash from Investing Activity Annual Cr -26-48
    Cash from Financing Annual Activity Cr -171
    Net Cash Flow Annual Cr 0-5
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 226202
    Fixed Assets Annual Cr 138134
    Total Non Current Assets Annual Cr 154149
    Total Current Assets Annual Cr 243208
    Total Assets Annual Cr 398357
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 218195
    ROE Annual % 1110
    ROCE Annual % 2021
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2225
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 809278706769
    Operating Expenses Qtr Cr 637161545457
    Operating Profit Qtr Cr 172117151411
    Depreciation Qtr Cr 455554
    Interest Qtr Cr 233222
    Tax Qtr Cr 32222-2
    Net Profit Qtr Cr 84865-7
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 309254
    Operating Expenses Annual Cr 241191
    Operating Profit Annual in Cr 6660
    Depreciation Cr 2015
    Interest Annual Cr 106
    Tax Annual Cr 76
    Net Profit Annual Cr 2419
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 4341
    Cash from Investing Activity Annual Cr -26-48
    Cash from Financing Annual Activity Cr -171
    Net Cash Flow Annual Cr -1-6
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 224201
    Fixed Assets Annual Cr 139135
    Total Non Current Assets Annual Cr 152146
    Total Current Assets Annual Cr 243207
    Total Assets Annual Cr 394354
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 215192
    ROE Annual % 1110
    ROCE Annual % 2021
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2225
    Invest in Kwality Pharmaceuticals

    Kwality Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹766.35
    -33.35 (-4.17%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹764.15
    • 50 Day
    • ₹674.02
    • 100 Day
    • ₹602.23
    • 200 Day
    • ₹532.42
    • 20 Day
    • ₹778.29
    • 50 Day
    • ₹631.32
    • 100 Day
    • ₹574.80
    • 200 Day
    • ₹510.92

    Kwality Pharmaceuticals Resistance and Support

    PIVOT
    ₹804.24
    Resistance
    First Resistance 815.47
    Second Resistance 831.23
    Third Resistance 842.47
    RSI 61.56
    MFI 59.61
    MACD Single Line 59.23
    MACD 52.12
    Support
    First Support 788.47
    Second Support 777.23
    Third Supoort 761.47

    Kwality Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 13,214 875,163 66.23
    Week 27,899 1,489,796 53.4
    1 Month 38,520 2,118,615 55
    6 Month 17,185 1,159,147 67.45

    Kwality Pharmaceuticals Result Highlights

    Kwality Pharmaceuticals Synopsis

    NSE-Food-Packaged

    M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 245.57 Cr. and Equity Capital is Rs. 37.54 Cr. for the Year ended 31/03/2024. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.
    Market Cap 351
    Sales 227
    Shares in Float 9.38
    No of funds 1
    Yield
    Book Value 5.74
    U/D Vol ratio 0.5
    LTDebt / Equity 5
    Alpha -1.08
    Beta -0.25

    Kwality Pharmaceuticals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 74.82%74.82%74.82%74.82%
    Foreign Portfolio Investors 0.02%0.02%
    Individual Investors 20.51%20.79%14.05%12.27%
    Others 4.65%4.37%11.13%12.91%

    Kwality Pharmaceuticals Management

    Name Designation
    Mr. Vinod Kumar Executive Director
    Mr. Raj Kumar Non Exe.Non Ind.Director
    Mr. Parvind Kumar Non Executive Director
    Mr. Parmod Kumar Managing & Executive Director
    Ms. Laxmi Mandal Ind. Non-Executive Director
    Mr. Tej Mohan Singh Ind. Non-Executive Director
    Mrs. Shipra Jain Ind. Non-Executive Director
    Mr. Swati Gupta Ind. Non-Executive Director

    Kwality Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Kwality Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-08-10 Quarterly Results
    2024-05-23 Audited Results
    2024-02-06 Quarterly Results
    2023-11-04 Quarterly Results
    2023-08-10 Quarterly Results

    Kwality Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Kwality Pharmaceuticals FAQs

    What is Share Price of Kwality Pharmaceuticals ?

    Kwality Pharmaceuticals share price is ₹766 As on 19 September, 2024 | 13:24

    What is the Market Cap of Kwality Pharmaceuticals ?

    The Market Cap of Kwality Pharmaceuticals is ₹795.2 Cr As on 19 September, 2024 | 13:24

    What is the P/E ratio of Kwality Pharmaceuticals ?

    The P/E ratio of Kwality Pharmaceuticals is 29.8 As on 19 September, 2024 | 13:24

    What is the PB ratio of Kwality Pharmaceuticals ?

    The PB ratio of Kwality Pharmaceuticals is 3.6 As on 19 September, 2024 | 13:24

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.